Hormone Refractory Prostate Cancer
Showing 1 - 25 of >10,000
Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))
Terminated
- Refractory Cancer
- BIBW 2992 (Afatinib)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Jun 29, 2022
Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)
Recruiting
- Metastatic Hormone Refractory Prostate Cancer
- Cabozantinib
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 6, 2022
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- GnRH agonist/antagonist
- +3 more
-
Los Angeles, California
- +3 more
Apr 30, 2021
Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)
Completed
- Hormone Refractory Prostate Cancer
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))
Completed
- Prostate Cancer
- LBH589 (i.v. panobinostat)
-
Rockville, Maryland
- +8 more
Dec 16, 2020
Prostate Cancer Trial in Canada (GTI-2040, docetaxel, prednisone)
Completed
- Prostate Cancer
- GTI-2040
- +2 more
-
Vancouver, British Columbia, Canada
- +4 more
Apr 23, 2021
Prostate Cancer Trial in Omaha (HyperAcute-Prostate Cancer Vaccine)
Completed
- Prostate Cancer
- HyperAcute-Prostate Cancer Vaccine
-
Omaha, NebraskaUniversity of Nebraska Medical Center
May 26, 2020
Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United
Active, not recruiting
- Prostate Carcinoma Metastatic to the Bone
- +2 more
- Niraparib
- Radium Ra 223 Dichloride
-
Birmingham, Alabama
- +5 more
Feb 10, 2021
Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer
- Rezvilutamide
- +2 more
- (no location specified)
Nov 10, 2023
Prostate Cancer Trial in Los Angeles (carboplatin, paclitaxel)
Completed
- Prostate Cancer
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Aug 17, 2020
Metastatic Hormone Refractory Prostate Cancer Trial in Worldwide (Patupilone, prednisone, docetaxel)
Completed
- Metastatic Hormone Refractory Prostate Cancer
- Patupilone
- +2 more
-
La Jolla, California
- +31 more
Dec 11, 2020
Learn More About How Safe Darolutamide is Under Real-world
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- No Intervention
-
Multiple Locations, JapanMany Locations
Aug 24, 2023
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery
Recruiting
- Prostate Cancer
- +6 more
- Radiotherapy (SBRT) and/or surgery (metastasectomy)
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Jun 7, 2022
Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)
Recruiting
- Metastatic Prostate Cancer
- +2 more
-
Nanjing, Jiangsu, ChinaUrology dpt, First Affiliated Hospital of Nanjing Medical Univer
Aug 2, 2023
Apalutamide in Metastatic Hormone Sensitive Prostate Cancer
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
-
Cardiff, United Kingdom
- +4 more
Aug 25, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022